Emily MacDuffie
Overview
Explore the profile of Emily MacDuffie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
MacDuffie E, Kernell C, George J, Bvochora-Nsingo M, Vuylsteke P, Bazzett-Matabele L, et al.
Gynecol Oncol
. 2025 Feb;
194:91-97.
PMID: 39983352
Objectives: Standard chemoradiation (CRT) treatment for cervical cancer was disrupted in Botswana during the COVID-19 pandemic. Patients were prescribed induction chemotherapy (IC) to bridge delays to radiotherapy (RT) or CRT...
2.
Bhangdia K, Natarajan A, Rudolfson N, Verguet S, Castro M, Dusengimana J, et al.
BMC Cancer
. 2025 Jan;
25(1):146.
PMID: 39865262
Background: Butaro Cancer Center of Excellence (BCCOE) was founded to serve Rwanda's rural low-income population, providing subsidized cancer diagnosis and treatment with transport stipends for the lowest-income patients. We examined...
3.
Pain D, MacDuffie E, Martei Y, Kassick M, Ikeda D, Shulman L, et al.
JCO Glob Oncol
. 2024 Oct;
10:e2400114.
PMID: 39447091
Low- and middle-income countries (LMICs) report disproportionally worse cancer mortality. Current global cancer control efforts focus predominantly on expanding access to multimodality treatment for patients, whereas less attention has been...
4.
LeCompte M, Gibbs I, Taparra K, Suneja G, Deville Jr C, White 2nd Z, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jun;
120(4):940-945.
PMID: 38944312
No abstract available.
5.
Grover S, MacDuffie E, Nsingo M, Lei X, Mehta P, Davey S, et al.
JCO Glob Oncol
. 2023 Sep;
9:e2200397.
PMID: 37738538
Purpose: Timely radiation treatment (RT) is critical in cervical cancer treatment, but patients in low- and middle-income countries (LMICs) in sub-Saharan Africa often face barriers that delay care. Time to...
6.
Kim K, LaRiviere M, MacDuffie E, White C, Jordan-Luft M, Anderson E, et al.
Pract Radiat Oncol
. 2022 Aug;
13(1):28-40.
PMID: 35917896
Purpose: Glucocorticoids are commonly used in patients with cancer for symptom relief or as part of their anticancer treatment. Despite their frequent use, indications and dosing regimens are not exclusively...
7.
Bhatia R, Lichter K, Gurram L, MacDuffie E, Lombe D, Sarria G, et al.
Int J Gynecol Cancer
. 2022 Mar;
32(3):446-450.
PMID: 35256435
The COVID-19 pandemic has forever affected healthcare and posed an incredible challenge to our society to care for our sick. Patients with cancer were found early on to have higher...
8.
Bhatia R, Lichter K, Gurram L, MacDuffie E, Lombe D, Sarria G, et al.
Int J Gynecol Cancer
. 2022 Mar;
32(3):421-428.
PMID: 35256432
A disproportionate burden of gynecologic malignancies occurs in low- and middle-income countries. Radiation therapy is an integral component of treatment for gynecologic malignancies both from a curative (locally advanced cervical...
9.
Lichter K, Anakwenze Akinfenwa C, MacDuffie E, Bhatia R, Small C, Croke J, et al.
Expert Rev Anticancer Ther
. 2022 Mar;
22(4):353-359.
PMID: 35227148
Introduction: Brachytherapy is an essential component of the cervical cancer treatment paradigm as it contributes to improved clinical outcomes and overall survival. Yet brachytherapy remains globally underutilized, with disparities in...
10.
MacDuffie E, Sakamuri S, Luckett R, Wang Q, Bvochara-Nsingo M, Monare B, et al.
Int J Gynecol Cancer
. 2021 Sep;
31(10):1328-1334.
PMID: 34493586
Objectives: Vulvar cancer is a rare gynecological malignancy. However, the incidence of human papillomavirus (HPV)-associated vulvar disease is increasing, particularly in low- and middle-income countries. HIV infection is associated with...